Uptake of temozolomide in a rat glioma model in the presence and absence of the angiogenesis inhibitor TNP-470

Cancer Research

Volumn 56, Issue 9, 1996, Pages 1983-1987

  Devineni, Damayanthi ^a   Klein Szanto, Andres ^a   Gallo, James M ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FUMAGILLOL CHLOROACETYLCARBAMATE; TEMOZOLOMIDE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; DOSE TIME EFFECT RELATION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFECT; DRUG EFFICACY; DRUG UPTAKE; GLIOMA; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR VASCULARIZATION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CYCLOHEXANES; DACARBAZINE; FACTOR VIII; GLIOMA; MICROSCOPY, CONFOCAL; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; RATS; SESQUITERPENES; TUMOR CELLS, CULTURED;

EID: 0029875694     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Liotta, L A., Steeg, P. S., and Stetler-Stevenson, W. G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64. 327-336, 1991
2. Folkman, J , and Shing, Y Angiogenesis. J Biol. Chem., 267: 10931-10934, 1991.
3. Fidler, I. J., and Ellis, L M. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell, 79: 185-188, 1994.
4. Brown, L F., Dvorak, A. M., and Dvorak, H. F. Leaky vessels, fibrin deposition and fibrosis: a sequence of events common to solid tumors and to many other types of disease. Am. Rev. Respir. Dis , 140: 1104-1107, 1989.
5. Samoto, K., Ikezaki, K., Ono, M., Shono, T., Kohno, K., Kuwano, M., and Fukui, M. Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors Cancer Res., 55. 1189-1193, 1995.
6. Senger, D R , Water, L. V. D., Brown, L. F. Nagy, J. A , Yeo, K. T., Yeo, T. K., Berse, B., Jackman, R. W., Dvorak, A M., and Dvorak, H. F. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev., 12. 303-324, 1993
7. Dvorak, H. F., Brown, L. F., Detmar, M., and Dvorak, A. M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J. Path . 146: 1029-1039, 1995
8. Billington, D C. Angiogenesis and its inhibition, potential new therapies in oncology and non-neoplastic diseases Drug Design Discovery, 8: 3-35, 1991.
9. Jain, R K. Transport of molecules in the tumor interstitium: a review. Cancer Res , 47: 3039-3051, 1987.
10. Plate, K. H., Breier, G., Weich, H A , and Risau, W. Vascular endothelial growth factor is a potential rumor angiogenesis factor in human gliomas in vivo. Nature (Lond.), 359: 845-848, 1992
11. Berkman, R. A., Merrill, M. J., Reinhold, W. C , Monacci, W. T., Saxena, A., Clark, W. C , Robertson, J. T., Ali, I U., and Oldfield, E. H. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms, J. Clin Invest., 91: 153-159, 1993
12. Goldman, C. K., Kim, J., Wong, W L , King, V., Brock, T., and Gillespie, G. Y. Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. Mol. Biol. Cell, 4. 121-133, 1993
13. Takahashi, Y , Kitadai, Y., Bucana, C. D., Cleary, K. R., and Ellis, L. M. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer Cancer Res., 55: 3964-3968, 1995.
14. Vries, C. D , Escobedo, J. A., Ueno, H . Houck, K., Ferrara, N , and Williams, L. T. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science (Washington DC). 222: 989-991, 1992.
15. Millauer, B , Wizigmann-Voos, S , Schnuren, H., Martinez, R., Moller, N. P. H., Risau, W., and Ullrich, A High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell, 72. 835-846, 1993.
16. Terman, B. I., Dougher-Vermazen, M., Carrion, M. E., Dimitrov, D., Aarmellino, D C., Gospodarowicz, D , and Bohlen, P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun , 187: 1579-1586, 1992.
17. Newlands, E. S., Blackledge, G. R. P., Slack, J A., Rustin, G. J S., Smith, D. B., Stuart, N. S. A., Quaterman, C. P., Hoffman, R., Stevens, M. F. G., Brampton, M. H., and Gibson, A. C. Phase I trial of temozolomide (CCRG 81045: M&B39831: NSC362856) Br. J. Cancer, 65. 287-291, 1992
18. O'Reilly, S. M., Newlands, E. S., Glaser, M. G., Brampton, M , Rice-Edwards, J. M , Illingwirth, R. D., Richards, P. G., Kennard, C., Colquhoun, I. R. Lewis, P., and Stevens, M. F. G Temozolomide: a new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumors Eur J. Cancer. 29A: 940-942, 1993.
19. Taki, T., Ohnishi, T., Arita, N., Hiraga, S., Saitoh, Y., Isumoto, S., Mori, K., and Hayakawa, T Anti-proliferative effects of TNP-470 on human malignant glioma in vivo: potent inhibition of tumor angiogenesis J. Neuro-Oncol., 19: 251-258, 1994.
20. Kato, T., Sato, K., Kakinuma, H., and Matsuda, Y. Enhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470) and cytotoxic agents in mice. Cancer Res., 54: 5143-5147, 1994.
21. Ingber, D., Fujita, T., Kishimoto, S., Sudo, K , Kanamaru, T., Brem, H , and Folkman, J Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth. Nature (Lond ), 348 555-557, 1990.
22. Plate, K H , Breier, G., Millauer, B., Ullrich, A., and Risau, W. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res., 53: 5822-5827, 1993.
23. Wang, Y., Wong, S. L., and Sawchuk, R. J. Microdialysis calibration using retrodialysis and zero-net flux: application to a study of the distribution of zidovudine to rabbit cerebrospinal fluid and thalamus. Pharm. Res., 10: 1411-1419, 1993.
24. Laub, P. B., and Gallo, J. M. NCOMP: a windows based computer program for noncompartmental analysis of pharmacokinetic data. J. Pharm. Sci , 85: 393-395, 1996.
25. McComb, R. D., Jones, T. R., Pizzo, S. V., and Bigner, D. Specificity and sensitivity of immunohistochemical detection of factor VIII/von Willebrand factor antigen in formalin-fixed paraffin-embedded tissue. J. Histochem. Cytochem., 30: 371-377, 1982.
26. Tsang, L. L. H., Farmer, P. B., and Gescher, A. Characterisation of urinary metabolites of temozolomide in humans and mice and evaluation of their cytotoxicity. Cancer Chemother. Pharmacol., 26: 429-436, 1990.
27. Stevens, M. F. G., Hickman, J. A., Langdon, S. P., Chubb, D., Vickers, L., Stone, R., Baig, G., Goddard, C., Gibson, N. W., Slack, J. A., Newton, C., Lunt, E., Fizames, C., and Lavelle, F. Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-unidazo(5,1-d)-1,2,3,5- tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine. Cancer Res., 47: 5846-5852, 1987.
28. Cretton-Scott, E., Placidi, L., McClure, H., Spandler, M., and Sommadossi, J-P., Pharmacokinetics of TNP-470, a potent angiogenesis inhibitor, in rhesus monkeys. Proc. Am. Assoc. Cancer Res., 36: 362, 1995.
29. Kohn, S., Nagy, J. A., and Dvorak, H. F. Pathways of macromolecular tracer transport across venules and small veins. Structural basis for the hyperpermeability of tumor blood vessels. Lab. Invest., 67: 596-607, 1992.
30. Hong, Q. H., Nagy, J. A., Senger, D. R., II, Dvorak, F., and Dvorak, A. M. Ultrastructural localization of vascular permeability factor/vascular endothelial growth factor (VPF/ VEGF) to the albuminal plasma membrane and vesiculovacuolar organelles of tumor microvascular endothelium. J. Histochem. Cytochem., 43: 381-389, 1995.
31. Teicher, B. A., Dupuis, N. P., and Robinson, M. F. Antiangiogenic treatment (TNP-470/minocycline) increases tissue levels of anticancer drugs in mice bearing Lewis lung carcinoma. Oncol Res., 7: 237-243, 1995.
32. Brem, H., Gresser, I., Grosfeld, J., and Folkman, J. The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis J. Pediatr. Surg., 28: 1253-1257, 1993